- Home
- LNZA vs MYO Comparison
LNZA vs MYO Comparison
Compare LNZA & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LNZA | MYO |
|---|---|---|
| Founded | 2005 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.6M | 39.2M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | LNZA | MYO |
|---|---|---|
| Price | $15.48 | $0.92 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $14.00 | $7.67 |
| AVG Volume (30 Days) | 8.0K | ★ 618.0K |
| Earning Date | 11-19-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $39,876,000.00 | ★ $41,643,203.00 |
| Revenue This Year | N/A | $24.07 |
| Revenue Next Year | $113.27 | $17.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 65.00 |
| 52 Week Low | $11.20 | $0.71 |
| 52 Week High | $166.99 | $6.45 |
Technical Indicators
Market Signals| Indicator | LNZA | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 54.94 | 46.00 |
| Support Level | $13.50 | $0.96 |
| Resistance Level | $14.43 | $1.05 |
| Average True Range (ATR) | 0.63 | 0.07 |
| MACD | 0.29 | -0.01 |
| Stochastic Oscillator | 71.02 | 9.68 |
Price Performance
Historical ComparisonAbout LNZA LanzaTech Global Inc.
LanzaTech Global Inc is a carbon management company transforming waste carbon into sustainable fuels, fabrics, packaging, and nutrition. Its goal is to advance a circular economy where carbon is reused rather than wasted, reducing reliance on virgin fossil resources and supporting supply chain resilience. The company operates in North America, Europe, Middle East, Africa (EMEA), Asia, and Australia.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).